Turnstone biologics to participate in upcoming investor conferences

San diego, feb. 21, 2024 (globe newswire) -- turnstone biologics corp. (“turnstone” or the “company”) (nasdaq: tsbx), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (selected til) therapy, today announced that members of its senior management team will participate in the following investor conferences: td cowen 44 th annual global health care conference       type:       presentation and one-on-one investor meetings speaker:   sammy farah, m.b.a., ph.d., president and chief executive officer date:   wednesday, march 6, 2024 presentation time:   2:10pm et / 11:10am pt location:   boston, ma       leerink partners global biopharma conference 2024       type:date:location:   one-on-one investor meetingswednesday, march 13, 2024miami, fl a live webcast of the presentation may be accessed on the events page of turnstone's investor relations website at https://ir.turnstonebio.com, where a replay will also be available for a limited period.
TSBX Ratings Summary
TSBX Quant Ranking